dibenzylchlorethamine has been researched along with Nerve Degeneration in 1 studies
Dibenzylchlorethamine: An alpha adrenergic antagonist.
Nerve Degeneration: Loss of functional activity and trophic degeneration of nerve axons and their terminal arborizations following the destruction of their cells of origin or interruption of their continuity with these cells. The pathology is characteristic of neurodegenerative diseases. Often the process of nerve degeneration is studied in research on neuroanatomical localization and correlation of the neurophysiology of neural pathways.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Langer, SZ | 1 |
1 other study available for dibenzylchlorethamine and Nerve Degeneration
| Article | Year |
|---|---|
The degeneration contraction of the nictitating membrane in the unanesthetized cat.
Topics: Animals; Cats; Denervation; Dibenzylchlorethamine; In Vitro Techniques; Muscle Contraction; Muscles; | 1966 |